|
|
|||||||||||
The British Journal of Psychiatry 139: 105-111 (1981)
© 1981 The Royal College of Psychiatrists
M Peet, MS Bethell, A Coates, AK Khamnee, P Hall, SJ Cooper, DJ King and RA Yates
Fifty-three hospitalized chronic schizophrenic patients were treated with either propranolol, chlorpromazine or placebo in a double-blind randomized trials for up to three months. Propranolol in a usual dose of 640 mg/day, produced marked cardiovascular effects but no improvement in schizophrenic symptomatology relative to placebo. The effects of chlorpromazine were small and inconsistent.
This article has been cited by other articles:
![]() |
J.F.W. Deakin, M.D.C. Simpson, P. Slater, and J.S.E. Hellewell Familial and developmental abnormalities of frontal lobe function and neurochemistry in schizophrenia J Psychopharmacol, January 1, 1997; 11(2): 133 - 142. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |